Not sure I follow. If the cost to produce a drug remains the same (or goes higher actually) but the potential payout is limited or lowered by restrictions on pricing, how are they not related?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.